Dr. Daniel Keith Shuman, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 625 Kentucky St, Ashland, KS 67831 Phone: 620-635-2241 |
Brianne Clark, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 709 W Oak, Ashland, KS 67831 Phone: 620-635-2241 |
Dr. Zachary Noah Gastelum, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 625 Kentucky St, Ashland, KS 67831 Phone: 620-635-2241 |
News Archive
Cell Therapeutics, Inc. today announced that it intends to appeal the U.S. Food and Drug Administration's previously disclosed decision regarding the pixantrone New Drug Application ("NDA") to treat patients with relapsed/refractory aggressive non-Hodgkin's lymphoma ("NHL").
A new study by Loyola University Health System researchers could lead to alternative treatments that would shrink skin cancer tumors with drugs. The drugs would work by turning on a gene that prevents skin cells from becoming cancerous, said senior author Mitchell Denning, Ph.D.
ChromoCure, Inc. (PINKSHEETS: KKUR) is pleased to announce the basis for the Company's technology confirmed by recent Mayo Clinic researchers. Their findings, which appear in the current issue of the journal Cancer Cell, along with an independent commentary on the discovery, end a major controversy in the field of cancer research as to whether aneuploidy is a cause or a consequence of cancer and further proves the aneuploidy basis of cancer.
A protein in mice known as RGS13 suppresses allergic reactions, including the severe, life-threatening allergic reaction known as anaphylaxis, according to scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).
University of Tsukuba-led team reveals the association between a gene variant and a lung disease in the form of systemic vasculitis particularly prevalent in the Japanese, potentially providing a target for future therapies.
› Verified 4 days ago